DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,948,674 | +0.6% | 7,854 | -2.7% | 0.18% | +4.0% |
Q2 2023 | $1,937,507 | -9.8% | 8,072 | -5.3% | 0.17% | -13.9% |
Q1 2023 | $2,148,912 | -6.7% | 8,526 | -1.7% | 0.20% | -14.4% |
Q4 2022 | $2,303,245 | -99.9% | 8,677 | +21.4% | 0.24% | +15.1% |
Q3 2022 | $1,845,753,000 | +2.3% | 7,146 | +0.4% | 0.20% | +3.0% |
Q2 2022 | $1,804,375,000 | -16.5% | 7,117 | -3.4% | 0.20% | -2.9% |
Q1 2022 | $2,160,796,000 | -11.3% | 7,366 | -0.5% | 0.20% | -9.3% |
Q4 2021 | $2,436,226,000 | +7.1% | 7,402 | -0.2% | 0.23% | +4.6% |
Q3 2021 | $2,274,951,000 | +11.9% | 7,420 | -1.2% | 0.22% | +9.6% |
Q2 2021 | $2,033,805,000 | +22.6% | 7,512 | +1.9% | 0.20% | +15.9% |
Q1 2021 | $1,659,497,000 | -0.9% | 7,372 | -2.1% | 0.17% | -10.1% |
Q4 2020 | $1,673,878,000 | +126.7% | 7,532 | +119.7% | 0.19% | +101.1% |
Q3 2020 | $738,374,000 | +27.7% | 3,429 | +4.9% | 0.09% | +19.0% |
Q2 2020 | $578,375,000 | +23.7% | 3,270 | -3.2% | 0.08% | +3.9% |
Q1 2020 | $467,621,000 | +35.7% | 3,378 | +40.2% | 0.08% | +81.0% |
Q2 2019 | $344,492,000 | +29.5% | 2,410 | +19.7% | 0.04% | +16.7% |
Q1 2019 | $265,928,000 | +42.3% | 2,014 | +11.1% | 0.04% | +28.6% |
Q4 2018 | $186,875,000 | -3.9% | 1,812 | +1.2% | 0.03% | +3.7% |
Q3 2018 | $194,518,000 | +22.5% | 1,790 | +11.2% | 0.03% | +17.4% |
Q2 2018 | $158,776,000 | +119280.5% | 1,609 | +18.0% | 0.02% | +9.5% |
Q1 2018 | $133,000 | -47.4% | 1,363 | -53.9% | 0.02% | -50.0% |
Q1 2017 | $253,000 | +10.5% | 2,959 | +0.6% | 0.04% | 0.0% |
Q4 2016 | $229,000 | -10.2% | 2,940 | +16.3% | 0.04% | -12.5% |
Q2 2016 | $255,000 | +4.1% | 2,527 | -2.1% | 0.05% | 0.0% |
Q1 2016 | $245,000 | 0.0% | 2,581 | -2.1% | 0.05% | -5.9% |
Q4 2015 | $245,000 | +20.7% | 2,637 | +10.7% | 0.05% | +10.9% |
Q3 2015 | $203,000 | -2.4% | 2,383 | -2.0% | 0.05% | -2.1% |
Q2 2015 | $208,000 | -1.0% | 2,431 | -1.7% | 0.05% | -2.1% |
Q1 2015 | $210,000 | -12.1% | 2,472 | -11.5% | 0.05% | +71.4% |
Q4 2014 | $239,000 | +16.0% | 2,794 | +2.9% | 0.03% | -42.9% |
Q3 2014 | $206,000 | -1.4% | 2,715 | +2.1% | 0.05% | -2.0% |
Q2 2014 | $209,000 | +0.5% | 2,658 | -21.3% | 0.05% | -71.3% |
Q2 2009 | $208,000 | – | 3,376 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |